← FDA DRUG APPROVALS

FDA ANDA · ANDA073467

TRIAMTERENE AND HYDROCHLOROTHIAZIDE

Sponsor: ANI PHARMS

APPLICATION
ANDA073467
TYPE
ANDA
ORIGINAL APPROVAL
1996-01-31
LATEST ACTION
2001-05-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRIAMTERENE AND HYDROCHLOROTHIAZIDEDiscontinued
HYDROCHLOROTHIAZIDE 50MG, TRIAMTERENE 75MG · TABLET · ORAL

Approval history

2001-05-29Manufacturing (CMC) · Supplement 5AP
2001-05-17Manufacturing (CMC) · Supplement 4AP
2000-07-07Manufacturing (CMC) · Supplement 3AP
2000-04-13Manufacturing (CMC) · Supplement 1AP
1997-08-08Labeling · Supplement 2AP
1996-01-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →